Form D · Biotechnology
Enquyst Technologies Inc.
Lowell, MA · CIK 0002071109
Offering snapshot reported Jun 13, 2025 · SEC filing
- Reported sold
- $6M Offering amount: $20.3M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 4, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 13, 2025 | Initial | $6,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-548896
conversion of SAFE's
Source: Form D, filed Jun 13, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Caillouette | Director |
| Jason Criscione | Director, Executive, Promoter |
| Vishal Jain | Director |
| Youssef Sebban | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
600 Suffolk Street, 2 Nd Floor
Lowell, MA, 01854
Lowell, MA, 01854